Bodycompany ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  27.5% 16.5% 20.7% 16.9% 14.9%  
Credit score (0-100)  3 10 4 9 13  
Credit rating  B BB B BB BB  
Credit limit (kDKK)  -0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -64.2 19.0 41.3 162 139  
EBITDA  -64.2 19.0 41.3 39.1 42.7  
EBIT  -64.8 16.1 37.9 35.7 39.3  
Pre-tax profit (PTP)  -65.3 14.7 37.0 36.6 42.4  
Net earnings  -51.2 11.5 28.8 28.7 32.8  
Pre-tax profit without non-rec. items  -65.3 14.7 37.0 36.8 42.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  11.8 13.4 10.0 6.6 3.2  
Shareholders equity total  -11.2 0.3 29.2 57.9 90.7  
Interest-bearing liabilities  35.5 24.6 3.8 12.9 16.0  
Balance sheet total (assets)  43.8 36.6 57.5 81.1 119  

Net Debt  20.1 1.9 -18.4 -26.1 -9.1  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -64.2 19.0 41.3 162 139  
Gross profit growth  0.0% 0.0% 116.8% 292.9% -14.2%  
Employees  0 0 0 0 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  44 37 58 81 119  
Balance sheet change%  0.0% -16.4% 57.1% 41.0% 46.6%  
Added value  -64.2 19.0 41.3 39.1 42.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  11 -1 -7 -7 -7  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  101.0% 84.6% 91.8% 22.0% 28.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -117.9% 35.1% 80.4% 53.1% 43.4%  
ROI %  -182.7% 53.3% 130.9% 71.0% 48.9%  
ROE %  -116.8% 52.1% 195.5% 66.0% 44.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -20.3% 0.9% 50.7% 71.3% 76.2%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -31.3% 9.9% -44.5% -66.8% -21.4%  
Gearing %  -317.5% 7,455.5% 13.0% 22.3% 17.7%  
Net interest  0 0 0 0 0  
Financing costs %  2.6% 4.6% 6.4% 0.0% 7.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.6 0.6 1.7 3.2 4.1  
Current Ratio  0.6 0.6 1.7 3.2 4.1  
Cash and cash equivalent  15.4 22.7 22.1 39.0 25.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -23.0 -13.1 19.2 51.3 87.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 43  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 43  
EBIT / employee  0 0 0 0 39  
Net earnings / employee  0 0 0 0 33